Summary
Medtronic plc announced on March 23, 2018, a strategic capital allocation plan that includes the redemption of approximately $1.2 billion of its subsidiary Medtronic, Inc.'s Senior Notes. Specifically, the company will redeem all outstanding 5.600% Senior Notes due 2019 and 4.450% Senior Notes due 2020. This move is driven by an assessment of an attractive opportunity to improve capital efficiency by reducing net interest expense and the overall cost of debt. In addition to debt reduction, Medtronic also intends to significantly increase its share repurchase program. The company plans to buy back a minimum of $1.2 billion of its ordinary shares during fiscal year 2019, separate from repurchases to offset employee stock dilution. These actions, funded by existing cash reserves, demonstrate Medtronic's commitment to enhancing shareholder value through both debt management and returning capital to investors.
Key Highlights
- 1Medtronic to redeem approximately $1.2 billion in Senior Notes (2019 and 2020 maturities).
- 2Redemption aims to lower net interest expense and average cost of debt, improving capital efficiency.
- 3Planned redemption date for the Senior Notes is April 27, 2018.
- 4Announced intention to repurchase a minimum of $1.2 billion of ordinary shares in FY2019.
- 5Share repurchases will be in addition to offsetting employee compensation dilution.
- 6These repurchases are part of the existing $5.0 billion share repurchase program.
- 7Both debt redemption and share repurchases will be funded by cash on hand.